Catalyst for a Cure 2017 Research Progress

The Catalyst for a Cure (CFC) researchers are working to identify new glaucoma biomarkers and develop technology to accurately measure those biomarkers in glaucoma patients. Glaucoma Research Foundation (San Francisco, CA) is funding this unique collaborative team of four laboratories with complementary skill sets spanning neuroscience, optical imaging, biomedical engineering, and clinical ophthalmology. Glaucoma Research Foundation established the Catalyst for a Cure Biomarker Initiative with the goal to help glaucoma patients preserve their vision. The CFC principal investigators are Alfredo Dubra, PhD, Jeffrey L. Goldberg, MD, PhD, Andrew Huberman, PhD, and Vivek Srinivasan, PhD.